ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $890,000 | -9.7% | 22,149 | -18.8% | 0.07% | -41.5% |
Q3 2021 | $986,000 | -66.6% | 27,284 | -62.1% | 0.12% | -73.8% |
Q2 2021 | $2,948,000 | +86.8% | 71,925 | +98.8% | 0.45% | +30.7% |
Q1 2021 | $1,578,000 | +280.2% | 36,173 | +336.7% | 0.34% | +165.4% |
Q4 2020 | $415,000 | – | 8,283 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
Brown University | 381,759 | $16,652,000 | 11.44% |
Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |